Marrazzo Jeffrey D 4
4 · Spark Therapeutics, Inc. · Filed Mar 19, 2019
Insider Transaction Report
Form 4
Marrazzo Jeffrey D
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2019-03-15$3.45/sh+49,940$172,293→ 355,215 total - Exercise/Conversion
Stock Option (right to buy)
2019-03-15−49,940→ 126,131 totalExercise: $3.45Exp: 2024-07-01→ Common Stock (49,940 underlying)
Footnotes (1)
- [F1]This option was granted on July 2, 2014 and vests over four years, with 25% of the shares underlying the option vesting on May 24, 2015, and the remainder vesting quarterly thereafter.